Financial Services - Banks - Regional - NASDAQ - US
$ 20.2
0.0991 %
$ 205 M
Market Cap
11.35
P/E
ESSA Bancorp, Inc. operates as a bank holding company for ESSA Bank & Trust that provides a range of financial services to individuals, families, and businesses in Pennsylvania. The company accepts savings accounts, interest bearing demand accounts, checking accounts, money market accounts, club accounts, certificates of deposit and IRAs, and other qualified plan accounts, as well as commercial checking accounts. Its loan portfolio includes first mortgage loans for the purchase, construction, or refinancing of one- to four-family residential real estate property; commercial real estate loans; home equity loans and lines of credit; and commercial and other consumer loans, as well as loans secured by deposits and personal unsecured loans.[ Read More ]
The intrinsic value of one ESSA stock under the base case scenario is HIDDEN Compared to the current market price of 20.2 USD, ESSA Bancorp, Inc. is HIDDEN
2. FUNDAMENTAL
ANALYSIS
Price Chart ESSA
FINANCIALS
112 M
REVENUE
21 M
OPERATING INCOME
18.6 M
NET INCOME
20.9 M
OPERATING CASH FLOW
-377 M
INVESTING CASH FLOW
414 M
FINANCING CASH FLOW
28.2 M
REVENUE
5.13 M
OPERATING INCOME
3.91 M
NET INCOME
6.56 M
OPERATING CASH FLOW
4.73 M
INVESTING CASH FLOW
37.5 M
FINANCING CASH FLOW
Balance Sheet Decomposition
ESSA Bancorp, Inc.
| Current Assets | 51.8 M |
| Cash & Short-Term Investments | 0 |
| Receivables | 0 |
| Other Current Assets | 51.8 M |
| Non-Current Assets | 2.14 B |
| Long-Term Investments | 36.8 M |
| PP&E | 11.3 M |
| Other Non-Current Assets | 2.09 B |
| Current Liabilities | 280 M |
| Accounts Payable | 0 |
| Short-Term Debt | 280 M |
| Other Current Liabilities | 0 |
| Non-Current Liabilities | 1.68 B |
| Long-Term Debt | 10 M |
| Other Non-Current Liabilities | 1.67 B |
EFFICIENCY
Earnings Waterfall
ESSA Bancorp, Inc.
| Revenue | 112 M |
| Cost Of Revenue | 0 |
| Gross Profit | 112 M |
| Operating Expenses | 15 M |
| Operating Income | 21 M |
| Other Expenses | 2.39 M |
| Net Income | 18.6 M |
RATIOS
100.00%
GROSS MARGIN
18.79%
OPERATING MARGIN
15.23%
NET MARGIN
7.37%
ROE
0.78%
ROA
3.27%
ROIC
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
ESSA Bancorp, Inc.
| Net Income | 18.6 M |
| Depreciation & Amortization | 2.12 M |
| Capital Expenditures | -955 K |
| Stock-Based Compensation | 1.36 M |
| Change in Working Capital | 1.4 M |
| Others | -3.15 M |
| Free Cash Flow | 19.9 M |
Wall Street Analysts Price Targets
ESSA Bancorp, Inc.
ESSA has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.00%
DIVIDEND YIELD
0.15 USD
DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership
ESSA Bancorp, Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
30.1 K USD 1
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
| Date | Value | Insider | Amount | Avg Price |
|---|---|---|---|---|
|
3 months ago
Aug 12, 2024
|
Sell 10.2 K USD
|
Grayuski Thomas J
Senior Vice President |
- 605
|
16.905 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.99 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.85 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.98 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.79 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.99 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.925 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.99 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.9 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.98 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.82 USD |
|
3 months ago
Jul 26, 2024
|
Sell 1.98 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
19.795 USD |
|
3 months ago
Jul 26, 2024
|
Sell 4.01 K USD
|
Grayuski Thomas J
Vice President |
- 200
|
20.06 USD |
|
3 months ago
Jul 26, 2024
|
Sell 4 K USD
|
Grayuski Thomas J
Vice President |
- 200
|
20.01 USD |
|
1 year ago
Sep 13, 2023
|
Bought 14.8 K USD
|
Gray Peter A
SEVP and COO |
+ 1000
|
14.85 USD |
|
1 year ago
Sep 06, 2023
|
Bought 7.62 K USD
|
Selig Robert C Jr
Director |
+ 500
|
15.23 USD |
|
1 year ago
Sep 06, 2023
|
Bought 7.82 K USD
|
Selig Robert C Jr
Director |
+ 500
|
15.63 USD |
|
1 year ago
Aug 25, 2023
|
Bought 39.8 K USD
|
Gray Peter A
SEVP and COO |
+ 2500
|
15.9 USD |
|
2 years ago
Aug 24, 2022
|
Bought 4.01 K USD
|
Selig Robert C Jr
Director |
+ 250
|
16.0315 USD |
|
2 years ago
Aug 24, 2022
|
Bought 3.99 K USD
|
Selig Robert C Jr
Director |
+ 250
|
15.95 USD |
|
2 years ago
Aug 24, 2022
|
Bought 4.03 K USD
|
Selig Robert C Jr
Director |
+ 250
|
16.1 USD |
|
1 year ago
Aug 23, 2023
|
Bought 8.11 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.22 USD |
|
1 year ago
Aug 22, 2023
|
Bought 8.3 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.59 USD |
|
1 year ago
Aug 22, 2023
|
Bought 8.09 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.17 USD |
|
1 year ago
Aug 22, 2023
|
Bought 4.05 K USD
|
Selig Robert C Jr
Director |
+ 250
|
16.19 USD |
|
1 year ago
Aug 22, 2023
|
Bought 8.18 K USD
|
Gray Peter A
SEVP and COO |
+ 500
|
16.35 USD |
|
1 year ago
Aug 21, 2023
|
Bought 8.28 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.55 USD |
|
1 year ago
Aug 18, 2023
|
Bought 8.44 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.87 USD |
|
1 year ago
Aug 18, 2023
|
Bought 8.33 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.66 USD |
|
1 year ago
Aug 17, 2023
|
Bought 8.31 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.62 USD |
|
1 year ago
Aug 17, 2023
|
Bought 8.28 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.56 USD |
|
1 year ago
Aug 16, 2023
|
Bought 8.14 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.28 USD |
|
1 year ago
Aug 15, 2023
|
Bought 1.66 K USD
|
Selig Robert C Jr
Director |
+ 100
|
16.65 USD |
|
1 year ago
Aug 15, 2023
|
Bought 3.33 K USD
|
Selig Robert C Jr
Director |
+ 200
|
16.64 USD |
|
1 year ago
Aug 15, 2023
|
Bought 11.6 K USD
|
Selig Robert C Jr
Director |
+ 700
|
16.63 USD |
|
1 year ago
Aug 15, 2023
|
Bought 8.34 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.69 USD |
|
1 year ago
Aug 15, 2023
|
Bought 16.9 K USD
|
Selig Robert C Jr
Director |
+ 1000
|
16.91 USD |
|
3 years ago
Oct 29, 2021
|
Bought 8.18 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.35 USD |
|
3 years ago
Oct 29, 2021
|
Bought 8.15 K USD
|
Selig Robert C Jr
Director |
+ 500
|
16.3 USD |
|
3 years ago
May 13, 2021
|
Bought 23.9 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 1549
|
15.44 USD |
|
3 years ago
May 13, 2021
|
Bought 3.09 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 200
|
15.43 USD |
|
3 years ago
May 13, 2021
|
Bought 3.08 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 200
|
15.42 USD |
|
3 years ago
May 13, 2021
|
Bought 786 USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 51
|
15.41 USD |
|
3 years ago
Jan 29, 2021
|
Bought 14.2 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 1000
|
14.2468 USD |
|
3 years ago
Dec 03, 2020
|
Sell 14.2 K USD
|
Grayuski Thomas J
Vice President |
- 900
|
15.75 USD |
|
4 years ago
Sep 17, 2020
|
Bought 6.3 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 500
|
12.59 USD |
|
4 years ago
Aug 24, 2020
|
Bought 13 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 1000
|
13 USD |
|
4 years ago
Mar 02, 2020
|
Sell 3.37 K USD
|
Olson Gary S
President and CEO |
- 198
|
17.02 USD |
|
5 years ago
Aug 02, 2019
|
Bought 1.16 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 80
|
14.5 USD |
|
5 years ago
Aug 02, 2019
|
Bought 3.06 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 211
|
14.48 USD |
|
5 years ago
Aug 02, 2019
|
Bought 10.3 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 709
|
14.49 USD |
|
5 years ago
Jul 26, 2019
|
Bought 2 K USD
|
Hangen Charles
EVP and COO |
+ 130
|
15.4 USD |
|
5 years ago
Jul 26, 2019
|
Bought 3.08 K USD
|
Hangen Charles
EVP and COO |
+ 200
|
15.38 USD |
|
5 years ago
Mar 01, 2019
|
Bought 16.2 K USD
|
Gordon Christine Davis
Director |
+ 1000
|
16.228 USD |
|
5 years ago
Jan 31, 2019
|
Bought 15.4 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 1000
|
15.35 USD |
|
5 years ago
Jan 31, 2019
|
Bought 2.3 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 150
|
15.36 USD |
|
5 years ago
Jan 31, 2019
|
Bought 7.68 K USD
|
Gray Peter A
EVP and Chief Banking Officer |
+ 500
|
15.35 USD |
|
5 years ago
Jan 29, 2019
|
Sell 15.1 K USD
|
Weekes Elizabeth B
Director |
- 1000
|
15.0981 USD |
|
5 years ago
Jan 29, 2019
|
Sell 15.3 K USD
|
Weekes Elizabeth B
Director |
- 1000
|
15.2652 USD |
|
5 years ago
Dec 10, 2018
|
Sell 9.07 K USD
|
Selitto Robert L
Vice President |
- 567
|
16 USD |
|
6 years ago
Oct 26, 2018
|
Sell 40 K USD
|
Henning Daniel J
Director |
- 2500
|
16 USD |
|
6 years ago
Oct 03, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.2 USD |
|
6 years ago
Oct 03, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.23 USD |
|
6 years ago
Oct 03, 2018
|
Sell 96.4 K USD
|
Olson Gary S
President and CEO |
- 5930
|
16.25 USD |
|
6 years ago
Oct 03, 2018
|
Sell 1.84 K USD
|
Olson Gary S
President and CEO |
- 113
|
16.26 USD |
|
6 years ago
Oct 01, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.24 USD |
|
6 years ago
Oct 01, 2018
|
Sell 18.3 K USD
|
Olson Gary S
President and CEO |
- 1124
|
16.25 USD |
|
6 years ago
Oct 01, 2018
|
Sell 1.63 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.26 USD |
|
6 years ago
Oct 01, 2018
|
Sell 1.2 K USD
|
Olson Gary S
President and CEO |
- 74
|
16.28 USD |
|
6 years ago
Oct 02, 2018
|
Sell 13 K USD
|
Olson Gary S
President and CEO |
- 800
|
16.25 USD |
|
6 years ago
Oct 02, 2018
|
Sell 1.63 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.26 USD |
|
6 years ago
Sep 27, 2018
|
Sell 4.54 K USD
|
Olson Gary S
President and CEO |
- 281
|
16.16 USD |
|
6 years ago
Sep 27, 2018
|
Sell 6.78 K USD
|
Olson Gary S
President and CEO |
- 419
|
16.17 USD |
|
6 years ago
Sep 27, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.18 USD |
|
6 years ago
Sep 27, 2018
|
Sell 13 K USD
|
Olson Gary S
President and CEO |
- 800
|
16.25 USD |
|
6 years ago
Sep 27, 2018
|
Sell 3.25 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.26 USD |
|
6 years ago
Sep 27, 2018
|
Sell 11.4 K USD
|
Olson Gary S
President and CEO |
- 700
|
16.3 USD |
|
6 years ago
Sep 28, 2018
|
Sell 3.23 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.15 USD |
|
6 years ago
Sep 28, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.2 USD |
|
6 years ago
Sep 28, 2018
|
Sell 6.49 K USD
|
Olson Gary S
President and CEO |
- 400
|
16.22 USD |
|
6 years ago
Sep 28, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.24 USD |
|
6 years ago
Sep 28, 2018
|
Sell 6.5 K USD
|
Olson Gary S
President and CEO |
- 400
|
16.25 USD |
|
6 years ago
Sep 27, 2018
|
Sell 4.54 K USD
|
Olson Gary S
President and CEO |
- 281
|
16.16 USD |
|
6 years ago
Sep 27, 2018
|
Sell 6.78 K USD
|
Olson Gary S
President and CEO |
- 419
|
16.17 USD |
|
6 years ago
Sep 27, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.18 USD |
|
6 years ago
Sep 27, 2018
|
Sell 13 K USD
|
Olson Gary S
President and CEO |
- 800
|
16.25 USD |
|
6 years ago
Sep 27, 2018
|
Sell 3.25 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.26 USD |
|
6 years ago
Sep 27, 2018
|
Sell 11.4 K USD
|
Olson Gary S
President and CEO |
- 700
|
16.3 USD |
|
6 years ago
Sep 28, 2018
|
Sell 3.23 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.15 USD |
|
6 years ago
Sep 28, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.2 USD |
|
6 years ago
Sep 28, 2018
|
Sell 6.49 K USD
|
Olson Gary S
President and CEO |
- 400
|
16.22 USD |
|
6 years ago
Sep 28, 2018
|
Sell 1.62 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.24 USD |
|
6 years ago
Sep 28, 2018
|
Sell 6.5 K USD
|
Olson Gary S
President and CEO |
- 400
|
16.25 USD |
|
6 years ago
Aug 31, 2018
|
Sell 3.76 K USD
|
Olson Gary S
President and CEO |
- 233
|
16.15 USD |
|
6 years ago
Aug 28, 2018
|
Sell 96.9 USD
|
Olson Gary S
President and CEO |
- 6
|
16.15 USD |
|
6 years ago
Aug 23, 2018
|
Sell 8.38 K USD
|
Olson Gary S
President and CEO |
- 519
|
16.15 USD |
|
6 years ago
Aug 23, 2018
|
Sell 3.24 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.2 USD |
|
6 years ago
Aug 23, 2018
|
Sell 3.24 K USD
|
Olson Gary S
President and CEO |
- 200
|
16.21 USD |
|
6 years ago
Aug 23, 2018
|
Sell 5.62 K USD
|
Olson Gary S
President and CEO |
- 346
|
16.25 USD |
|
6 years ago
Aug 23, 2018
|
Sell 1.64 K USD
|
Olson Gary S
President and CEO |
- 100
|
16.4 USD |
|
6 years ago
Aug 24, 2018
|
Sell 4.56 K USD
|
Olson Gary S
President and CEO |
- 282
|
16.17 USD |
|
6 years ago
Aug 24, 2018
|
Sell 1.17 K USD
|
Olson Gary S
President and CEO |
- 72
|
16.2 USD |
|
6 years ago
Aug 09, 2018
|
Sell 170 K USD
|
Olson Gary S
President and CEO |
- 10600
|
16 USD |
|
6 years ago
Aug 07, 2018
|
Sell 3.2 K USD
|
Olson Gary S
President and CEO |
- 200
|
16 USD |
|
6 years ago
Aug 08, 2018
|
Sell 16 USD
|
Olson Gary S
President and CEO |
- 1
|
16 USD |
|
6 years ago
Jul 24, 2018
|
Sell 2 K USD
|
Olson Gary S
President and CEO |
- 125
|
16 USD |
|
6 years ago
Jul 25, 2018
|
Sell 112 USD
|
Olson Gary S
President and CEO |
- 7
|
16 USD |
|
6 years ago
Jul 20, 2018
|
Sell 1.68 K USD
|
Olson Gary S
President and CEO |
- 105
|
16 USD |
|
6 years ago
Jul 23, 2018
|
Sell 16 USD
|
Olson Gary S
President and CEO |
- 1
|
16 USD |
|
6 years ago
Jun 12, 2018
|
Sell 82.9 K USD
|
Reimer Diane K
Senior Vice President |
- 5350
|
15.5 USD |
|
6 years ago
Jun 13, 2018
|
Sell 83.5 K USD
|
Reimer Diane K
Senior Vice President |
- 5350
|
15.6 USD |
|
6 years ago
May 10, 2018
|
Sell 221 K USD
|
Muto Allan A
EVP and CFO |
- 14983
|
14.75 USD |
|
6 years ago
May 10, 2018
|
Sell 11.8 K USD
|
Muto Allan A
EVP and CFO |
- 800
|
14.76 USD |
|
6 years ago
May 10, 2018
|
Sell 2.95 K USD
|
Muto Allan A
EVP and CFO |
- 200
|
14.77 USD |
|
6 years ago
May 10, 2018
|
Sell 37.4 K USD
|
Muto Allan A
EVP and CFO |
- 2524
|
14.8 USD |
|
6 years ago
May 10, 2018
|
Sell 2.96 K USD
|
Muto Allan A
EVP and CFO |
- 200
|
14.81 USD |
|
6 years ago
May 10, 2018
|
Sell 2.96 K USD
|
Muto Allan A
EVP and CFO |
- 200
|
14.82 USD |
|
6 years ago
May 10, 2018
|
Sell 10.2 K USD
|
Muto Allan A
EVP and CFO |
- 688
|
14.83 USD |
|
6 years ago
May 10, 2018
|
Sell 5.61 K USD
|
Muto Allan A
EVP and CFO |
- 378
|
14.84 USD |
|
6 years ago
May 10, 2018
|
Sell 1.49 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
14.88 USD |
|
6 years ago
May 10, 2018
|
Sell 1.49 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
14.89 USD |
|
6 years ago
May 10, 2018
|
Sell 3.16 K USD
|
Muto Allan A
EVP and CFO |
- 212
|
14.9 USD |
|
6 years ago
May 10, 2018
|
Sell 1.49 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
14.91 USD |
|
6 years ago
Apr 17, 2018
|
Sell 338 K USD
|
Olson Gary S
President and CEO |
- 22918
|
14.75 USD |
|
6 years ago
Apr 06, 2018
|
Sell 91.4 K USD
|
Olson Gary S
President and CEO |
- 6200
|
14.75 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.76 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.761 USD |
|
6 years ago
Apr 06, 2018
|
Sell 8.86 K USD
|
Olson Gary S
President and CEO |
- 600
|
14.7667 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.77 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.7745 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.7754 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.778 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.79 USD |
|
6 years ago
Apr 06, 2018
|
Sell 7.4 K USD
|
Olson Gary S
President and CEO |
- 500
|
14.8 USD |
|
6 years ago
Apr 06, 2018
|
Sell 2.96 K USD
|
Olson Gary S
President and CEO |
- 200
|
14.8049 USD |
|
6 years ago
Apr 06, 2018
|
Sell 1.15 K USD
|
Olson Gary S
President and CEO |
- 78
|
14.8055 USD |
|
6 years ago
Apr 06, 2018
|
Sell 7.73 K USD
|
Olson Gary S
President and CEO |
- 522
|
14.81 USD |
|
6 years ago
Apr 09, 2018
|
Sell 2.99 K USD
|
Olson Gary S
President and CEO |
- 203
|
14.75 USD |
|
6 years ago
Mar 29, 2018
|
Sell 4.78 K USD
|
Olson Gary S
President and CEO |
- 324
|
14.75 USD |
|
6 years ago
Mar 13, 2018
|
Sell 30.5 K USD
|
Olson Gary S
President and CEO |
- 2071
|
14.75 USD |
|
6 years ago
Mar 13, 2018
|
Sell 8.41 K USD
|
Olson Gary S
President and CEO |
- 570
|
14.76 USD |
|
6 years ago
Mar 13, 2018
|
Sell 6.72 K USD
|
Olson Gary S
President and CEO |
- 455
|
14.77 USD |
|
6 years ago
Mar 13, 2018
|
Sell 1.56 K USD
|
Olson Gary S
President and CEO |
- 105
|
14.81 USD |
|
6 years ago
Mar 13, 2018
|
Sell 1.41 K USD
|
Olson Gary S
President and CEO |
- 95
|
14.79 USD |
|
6 years ago
Mar 13, 2018
|
Sell 3.02 K USD
|
Olson Gary S
President and CEO |
- 204
|
14.78 USD |
|
6 years ago
Mar 09, 2018
|
Sell 4.46 K USD
|
Olson Gary S
President and CEO |
- 300
|
14.87 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.49 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.86 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.84 USD |
|
6 years ago
Mar 09, 2018
|
Sell 2.92 K USD
|
Olson Gary S
President and CEO |
- 198
|
14.75 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.51 K USD
|
Olson Gary S
President and CEO |
- 102
|
14.78 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.79 USD |
|
6 years ago
Mar 09, 2018
|
Sell 178 USD
|
Olson Gary S
President and CEO |
- 12
|
14.8 USD |
|
6 years ago
Mar 09, 2018
|
Sell 5.73 K USD
|
Olson Gary S
President and CEO |
- 388
|
14.77 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.76 USD |
|
6 years ago
Mar 12, 2018
|
Sell 2.53 K USD
|
Olson Gary S
President and CEO |
- 170
|
14.87 USD |
|
6 years ago
Mar 12, 2018
|
Sell 9.35 K USD
|
Olson Gary S
President and CEO |
- 630
|
14.84 USD |
|
6 years ago
Mar 12, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.82 USD |
|
6 years ago
Mar 12, 2018
|
Sell 1.48 K USD
|
Olson Gary S
President and CEO |
- 100
|
14.81 USD |
|
6 years ago
Mar 12, 2018
|
Sell 13.3 K USD
|
Olson Gary S
President and CEO |
- 900
|
14.75 USD |
|
6 years ago
Mar 12, 2018
|
Sell 20.6 K USD
|
Olson Gary S
President and CEO |
- 1395
|
14.76 USD |
|
6 years ago
Mar 12, 2018
|
Sell 666 USD
|
Olson Gary S
President and CEO |
- 45
|
14.79 USD |
|
6 years ago
Mar 09, 2018
|
Sell 91.6 K USD
|
Muto Allan A
EVP and CFO |
- 6359
|
14.4 USD |
|
6 years ago
Mar 09, 2018
|
Sell 8.7 K USD
|
Muto Allan A
EVP and CFO |
- 600
|
14.5 USD |
|
6 years ago
Mar 09, 2018
|
Sell 10.2 K USD
|
Muto Allan A
EVP and CFO |
- 700
|
14.51 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.41 K USD
|
Muto Allan A
EVP and CFO |
- 97
|
14.52 USD |
|
6 years ago
Mar 09, 2018
|
Sell 1.45 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
14.53 USD |
|
6 years ago
Mar 09, 2018
|
Sell 2.94 K USD
|
Muto Allan A
EVP and CFO |
- 200
|
14.72 USD |
|
6 years ago
Mar 09, 2018
|
Sell 8.5 K USD
|
Selitto Robert L
Vice President |
- 595
|
14.29 USD |
|
6 years ago
Mar 08, 2018
|
Sell 114 K USD
|
Muto Allan A
EVP and CFO |
- 7919
|
14.4 USD |
|
6 years ago
Feb 02, 2018
|
Bought 61.8 K USD
|
Olson Gary S
President and CEO |
+ 5000
|
12.35 USD |
|
6 years ago
Jan 26, 2018
|
Sell 137 K USD
|
Grayuski Thomas J
Vice President |
- 8349
|
16.35 USD |
|
6 years ago
Jan 26, 2018
|
Sell 553 USD
|
Grayuski Thomas J
Vice President |
- 34
|
16.26 USD |
|
6 years ago
Nov 29, 2017
|
Sell 4.84 K USD
|
Grayuski Thomas J
Vice President |
- 300
|
16.15 USD |
|
6 years ago
Nov 29, 2017
|
Sell 42 K USD
|
Grayuski Thomas J
Vice President |
- 2600
|
16.17 USD |
|
6 years ago
Nov 29, 2017
|
Sell 4.06 K USD
|
Grayuski Thomas J
Vice President |
- 251
|
16.18 USD |
|
6 years ago
Nov 29, 2017
|
Sell 22.5 K USD
|
Grayuski Thomas J
Vice President |
- 1391
|
16.19 USD |
|
6 years ago
Nov 29, 2017
|
Sell 3.24 K USD
|
Grayuski Thomas J
Vice President |
- 200
|
16.2 USD |
|
6 years ago
Nov 29, 2017
|
Sell 1.62 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
16.25 USD |
|
7 years ago
Nov 03, 2017
|
Sell 40.2 K USD
|
Grayuski Thomas J
Vice President |
- 2500
|
16.1 USD |
|
7 years ago
Nov 03, 2017
|
Sell 25.8 K USD
|
Grayuski Thomas J
Vice President |
- 1600
|
16.12 USD |
|
7 years ago
Nov 03, 2017
|
Sell 38 K USD
|
Grayuski Thomas J
Vice President |
- 2354
|
16.13 USD |
|
7 years ago
Nov 03, 2017
|
Sell 1.61 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
16.14 USD |
|
7 years ago
Nov 03, 2017
|
Sell 1.61 K USD
|
Grayuski Thomas J
Vice President |
- 100
|
16.15 USD |
|
7 years ago
Oct 27, 2017
|
Sell 1.97 K USD
|
Grayuski Thomas J
Vice President |
- 121
|
16.25 USD |
|
7 years ago
Oct 27, 2017
|
Bought 19.3 K USD
|
Durkin Joseph S
Director |
+ 1192
|
16.1999 USD |
|
7 years ago
Oct 27, 2017
|
Bought 129 USD
|
Durkin Joseph S
Director |
+ 8
|
16.13 USD |
|
7 years ago
Oct 02, 2017
|
Sell 57.9 K USD
|
Olson Gary S
President and CEO |
- 3624
|
15.97 USD |
|
7 years ago
Sep 25, 2017
|
Sell 121 K USD
|
Olson Gary S
President and CEO |
- 8000
|
15.07 USD |
|
7 years ago
Sep 18, 2017
|
Sell 120 K USD
|
Olson Gary S
President and CEO |
- 8000
|
14.95 USD |
|
7 years ago
Sep 11, 2017
|
Sell 118 K USD
|
Olson Gary S
President and CEO |
- 8000
|
14.81 USD |
|
7 years ago
Sep 05, 2017
|
Sell 119 K USD
|
Olson Gary S
President and CEO |
- 8000
|
14.8284 USD |
|
7 years ago
Aug 28, 2017
|
Sell 1.35 K USD
|
Olson Gary S
President and CEO |
- 90
|
15.02 USD |
|
7 years ago
Aug 28, 2017
|
Sell 149 USD
|
Olson Gary S
President and CEO |
- 10
|
14.86 USD |
|
7 years ago
Aug 28, 2017
|
Sell 117 K USD
|
Olson Gary S
President and CEO |
- 7900
|
14.81 USD |
|
7 years ago
Jun 08, 2017
|
Sell 7.42 K USD
|
Henning Daniel J
Director |
- 500
|
14.85 USD |
|
7 years ago
Jun 08, 2017
|
Sell 7.36 K USD
|
Henning Daniel J
Director |
- 500
|
14.72 USD |
|
7 years ago
Jun 08, 2017
|
Sell 7.38 K USD
|
Henning Daniel J
Director |
- 500
|
14.77 USD |
|
7 years ago
Jun 06, 2017
|
Sell 7.36 K USD
|
Henning Daniel J
Director |
- 500
|
14.73 USD |
|
7 years ago
Jun 06, 2017
|
Sell 4.3 K USD
|
Henning Daniel J
Director |
- 291
|
14.79 USD |
|
7 years ago
Jun 07, 2017
|
Sell 2.15 K USD
|
Henning Daniel J
Director |
- 146
|
14.72 USD |
|
7 years ago
May 26, 2017
|
Sell 5.19 K USD
|
Henning Daniel J
Director |
- 353
|
14.7159 USD |
|
7 years ago
May 26, 2017
|
Sell 2.94 K USD
|
Henning Daniel J
Director |
- 200
|
14.7 USD |
|
7 years ago
May 26, 2017
|
Sell 709 USD
|
Henning Daniel J
Director |
- 48
|
14.78 USD |
|
7 years ago
May 25, 2017
|
Sell 31.7 K USD
|
Henning Daniel J
Director |
- 2167
|
14.65 USD |
|
7 years ago
May 25, 2017
|
Sell 13.8 K USD
|
Henning Daniel J
Director |
- 942
|
14.66 USD |
|
7 years ago
May 25, 2017
|
Sell 73.3 USD
|
Henning Daniel J
Director |
- 5
|
14.67 USD |
|
7 years ago
May 25, 2017
|
Sell 1.26 K USD
|
Henning Daniel J
Director |
- 86
|
14.68 USD |
|
7 years ago
May 10, 2017
|
Sell 14.7 K USD
|
Viechnicki William A
Director |
- 1002
|
14.7 USD |
|
7 years ago
May 10, 2017
|
Sell 1.47 K USD
|
Viechnicki William A
Director |
- 100
|
14.7001 USD |
|
7 years ago
May 10, 2017
|
Sell 3.07 K USD
|
Viechnicki William A
Director |
- 208
|
14.76 USD |
|
7 years ago
May 10, 2017
|
Sell 1.47 K USD
|
Viechnicki William A
Director |
- 100
|
14.74 USD |
|
7 years ago
May 10, 2017
|
Sell 1.13 K USD
|
Viechnicki William A
Director |
- 77
|
14.72 USD |
|
7 years ago
May 10, 2017
|
Sell 1.48 K USD
|
Viechnicki William A
Director |
- 100
|
14.755 USD |
|
7 years ago
May 10, 2017
|
Sell 2.95 K USD
|
Viechnicki William A
Director |
- 200
|
14.75 USD |
|
7 years ago
May 10, 2017
|
Sell 1.48 K USD
|
Viechnicki William A
Director |
- 100
|
14.79 USD |
|
7 years ago
May 10, 2017
|
Sell 1.67 K USD
|
Viechnicki William A
Director |
- 113
|
14.8 USD |
|
7 years ago
May 05, 2017
|
Sell 1.48 K USD
|
Bryant V Gail
Senior Vice President |
- 100
|
14.8 USD |
|
7 years ago
May 05, 2017
|
Sell 29.1 K USD
|
Bryant V Gail
Senior Vice President |
- 1967
|
14.77 USD |
|
7 years ago
May 05, 2017
|
Sell 6.39 K USD
|
Bryant V Gail
Senior Vice President |
- 433
|
14.75 USD |
|
7 years ago
May 05, 2017
|
Sell 12.5 K USD
|
Bryant V Gail
Senior Vice President |
- 850
|
14.71 USD |
|
7 years ago
May 03, 2017
|
Sell 36.8 K USD
|
Bryant V Gail
Senior Vice President |
- 2500
|
14.71 USD |
|
7 years ago
May 01, 2017
|
Sell 37.3 K USD
|
Bryant V Gail
Senior Vice President |
- 2500
|
14.92 USD |
|
7 years ago
May 02, 2017
|
Sell 37.3 K USD
|
Bryant V Gail
Senior Vice President |
- 2500
|
14.92 USD |
|
7 years ago
May 01, 2017
|
Bought 15 K USD
|
Gray Peter A
Dir. of Strategic Initiatives |
+ 1000
|
14.98 USD |
|
7 years ago
Mar 13, 2017
|
Sell 6.92 K USD
|
Bryant V Gail
Senior Vice President |
- 454
|
15.25 USD |
|
7 years ago
Mar 08, 2017
|
Sell 219 K USD
|
Bryant V Gail
Senior Vice President |
- 14133
|
15.5 USD |
|
7 years ago
Mar 09, 2017
|
Sell 16.5 K USD
|
Bryant V Gail
Senior Vice President |
- 1067
|
15.5 USD |
|
7 years ago
Mar 10, 2017
|
Sell 15.5 USD
|
Bryant V Gail
Senior Vice President |
- 1
|
15.5 USD |
|
7 years ago
Mar 06, 2017
|
Sell 1.58 K USD
|
Bryant V Gail
Senior Vice President |
- 100
|
15.75 USD |
|
7 years ago
Mar 07, 2017
|
Sell 127 K USD
|
Bryant V Gail
Senior Vice President |
- 8092
|
15.75 USD |
|
7 years ago
Mar 01, 2017
|
Sell 34.1 K USD
|
Bryant V Gail
Senior Vice President |
- 2127
|
16.01 USD |
|
7 years ago
Feb 27, 2017
|
Sell 47 K USD
|
Bryant V Gail
Senior Vice President |
- 2850
|
16.48 USD |
|
7 years ago
Feb 27, 2017
|
Sell 9.81 K USD
|
Bryant V Gail
Senior Vice President |
- 600
|
16.35 USD |
|
7 years ago
Feb 28, 2017
|
Sell 3.43 K USD
|
Bryant V Gail
Senior Vice President |
- 211
|
16.25 USD |
|
7 years ago
Feb 21, 2017
|
Sell 32.3 K USD
|
Muto Allan A
EVP and CFO |
- 1957
|
16.5 USD |
|
7 years ago
Feb 21, 2017
|
Sell 1.66 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
16.55 USD |
|
7 years ago
Feb 21, 2017
|
Sell 331 USD
|
Muto Allan A
EVP and CFO |
- 20
|
16.57 USD |
|
7 years ago
Feb 21, 2017
|
Sell 1.77 K USD
|
Muto Allan A
EVP and CFO |
- 107
|
16.58 USD |
|
7 years ago
Feb 21, 2017
|
Sell 1.66 K USD
|
Muto Allan A
EVP and CFO |
- 100
|
16.59 USD |
|
7 years ago
Feb 21, 2017
|
Sell 3.98 K USD
|
Muto Allan A
EVP and CFO |
- 240
|
16.6 USD |
|
7 years ago
Feb 14, 2017
|
Sell 42 K USD
|
Grayuski Thomas J
Vice President |
- 2603
|
16.14 USD |
|
7 years ago
Feb 15, 2017
|
Sell 288 K USD
|
Grayuski Thomas J
Vice President |
- 17882
|
16.1 USD |
|
7 years ago
Feb 02, 2017
|
Sell 151 K USD
|
Selitto Robert L
Vice President |
- 9586
|
15.73 USD |
|
7 years ago
Feb 03, 2017
|
Sell 79.3 K USD
|
Selitto Robert L
Vice President |
- 5119
|
15.5 USD |
|
7 years ago
Feb 03, 2017
|
Sell 701 USD
|
Selitto Robert L
Vice President |
- 45
|
15.58 USD |
|
7 years ago
Feb 03, 2017
|
Sell 3.92 K USD
|
Selitto Robert L
Vice President |
- 250
|
15.7 USD |
|
7 years ago
Jan 27, 2017
|
Sell 4.85 K USD
|
Reimer Diane K
Senior Vice President |
- 302
|
16.07 USD |
|
7 years ago
Jan 27, 2017
|
Sell 23.1 K USD
|
Reimer Diane K
Senior Vice President |
- 1440
|
16.06 USD |
|
7 years ago
Jan 27, 2017
|
Sell 9.63 K USD
|
Reimer Diane K
Senior Vice President |
- 600
|
16.05 USD |
|
7 years ago
Jan 27, 2017
|
Sell 209 USD
|
Selitto Robert L
Vice President |
- 13
|
16.1 USD |
|
7 years ago
Jan 27, 2017
|
Sell 4.85 K USD
|
Selitto Robert L
Vice President |
- 303
|
16.02 USD |
|
7 years ago
Jan 27, 2017
|
Sell 784 USD
|
Selitto Robert L
Vice President |
- 49
|
16.01 USD |
|
7 years ago
Jan 27, 2017
|
Sell 1.79 K USD
|
Selitto Robert L
Vice President |
- 112
|
15.98 USD |
7. News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
NEW YORK CITY, NY / ACCESSWIRE / November 16, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 13 hours ago
ATTENTION ESSA Pharma Inc. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
NEW YORK, NY / ACCESSWIRE / November 14, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ESSA Pharma Inc. ("ESSA Pharma Inc.") (NASDAQ:EPIX) concerning possible violations of federal securities laws. On October 31, 2024, ESSA announced that it was ending its Phase 2 trial for a prostate cancer treatment which tested masofaniten with enzalutamide versus enzalutamide alone in patients with metastatic castration-resistant prostate cancer who had not yet used second-generation antiandrogens.
accesswire.com
- 2 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
NEW YORK CITY, NY / ACCESSWIRE / November 14, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 2 days ago
ESSA Pharma Inc. Investigation Ongoing: Contact Levi & Korsinsky About Potential Securities Fraud Allegations - EPIX
NEW YORK, NY / ACCESSWIRE / November 12, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of ESSA Pharma Inc. ("ESSA Pharma Inc.") (NASDAQ:EPIX) concerning possible violations of federal securities laws. On October 31, 2024, ESSA announced that it was ending its Phase 2 trial for a prostate cancer treatment which tested masofaniten with enzalutamide versus enzalutamide alone in patients with metastatic castration-resistant prostate cancer who had not yet used second-generation antiandrogens.
accesswire.com
- 4 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
NEW YORK CITY, NY / ACCESSWIRE / November 12, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 4 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ESSA Pharma Inc. - EPIX
NEW YORK, NY / ACCESSWIRE / November 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ:EPIX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
accesswire.com
- 2 weeks ago
ESSA Pharma Announces Termination of Phase 2 Study Evaluating Masofaniten Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer
Efficacy signals observed will not achieve ESSA's target product profile in patients with metastatic castration-resistant prostate cancer naïve to second-generation antiandrogens A futility analysis conducted as part of a protocol-specified interim review of the safety, PK and efficacy data showed the single-agent enzalutamide control arm performing better than historical controls and similar to the combination of masofaniten and enzalutamide and therefore, unlikely to achieve the primary endpoint of the study Additional clinical studies with masofaniten including the combination study with abiraterone acetate and apalutamide as well as the remaining investigator sponsored trials will also be terminated and the IND and CTAs in different geographies will be withdrawn Company will initiate a process to explore and review strategic options focused on maximizing shareholder value SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Oct. 31, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that it has made the decision to terminate the Phase 2 clinical trial evaluating in a 2:1 randomization masofaniten combined with enzalutamide versus enzalutamide single agent in patients with metastatic castration-resistant prostate cancer ("mCRPC") naïve to second-generation antiandrogens. This decision, mutually agreed upon by both senior management and the board of directors, was based on a protocol-specified interim review of the safety, PK and efficacy data, which showed a much higher rate of PSA90 response in patients treated with enzalutamide monotherapy (which is standard of care for this patient population) than were expected based upon historical data.
prnewswire.com
- 2 weeks ago
ESSA Bancorp, Inc. Announces Fiscal Fourth Quarter, Full Year 2024 Financial Results
STROUDSBURG, PA / ACCESSWIRE / October 23, 2024 / ESSA Bancorp, Inc. (the "Company") (NASDAQ:ESSA), the holding company for ESSA Bank & Trust (the "Bank"), a $2.2 billion asset financial institution providing full service commercial and retail banking, asset management and trust, and investment services in eastern Pennsylvania, today announced financial results for the fiscal fourth quarter and full year ended September 30, 2024. Net income was $4.2 million, or $0.44 per diluted share, for the three months ended September 30, 2024, compared with $4.6 million, or $0.47 per diluted share, for the three months ended September 30, 2023.
accesswire.com
- 3 weeks ago
ESSA Pharma Presents Updated Phase 1/2 Masofaniten (EPI-7386) Clinical Data at the 2024 ESMO Congress
Combination of masofaniten plus enzalutamide continues to be well tolerated with durable reductions in PSA in patients with mCRPC Phase 2 dose expansion currently underway at the RP2CDs of masofaniten 600 mg BID in combination with enzalutamide 160 mg QD Across all dosing cohorts, 88% of patients achieved PSA90, 69% of patients achieved PSA90 in less than 90 days, and 63% of patients achieved PSA
prnewswire.com
- 2 months ago
ESSA Pharma to Present at the 2024 Cantor Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC , Sept.
prnewswire.com
- 2 months ago
ESSA Bancorp, Inc. Declares Quarterly Dividend
STROUDSBURG, PA / ACCESSWIRE / August 28, 2024 / ESSA Bancorp, Inc. (NASDAQ Global MarketSM:ESSA), the holding company for ESSA Bank & Trust, today announced that its Board of Directors declared a dividend of fifteen cents ($0.15) per share. The dividend is payable to shareholders of record as of September 16, 2024, payable on September 30, 2024.
accesswire.com
- 2 months ago
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2024
On track to report updated Phase 1 masofaniten plus enzalutamide dose escalation data in patients with mCRPC naïve to second generation antiandrogens in the second half of 2024 Presentation of Phase 1b monotherapy results expected to be reported in the second half of 2024 Phase 2 dose expansion underway evaluating masofaniten plus enzalutamide in patients with mCRPC naïve to second generation antiandrogens; ESSA projecting completion of enrollment in the first quarter of 2025, with preliminary data expected in mid-2025 Cash runway sufficient to fund operations well beyond 2025 SOUTH SAN FRANCISCO, California and VANCOUVER, Canada , Aug. 5, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal third quarter ended June 30, 2024. "With continued focus on execution, we are progressing towards a stream of significant milestones throughout the next nine to twelve months, with the first being the presentation at ESMO of more mature durability data from the Phase 1 dose escalation study evaluating masofaniten combined with enzalutamide in patients with metastatic castration-resistant prostate cancer naïve to second-generation antiandrogens," said David Parkinson, MD, President and CEO of ESSA.
prnewswire.com
- 3 months ago
8. Profile Summary
ESSA Bancorp, Inc. ESSA
COUNTRY
US
INDUSTRY
Banks - Regional
MARKET CAP
$ 205 M
Dividend Yield
0.00%
Description
ESSA Bancorp, Inc. operates as a bank holding company for ESSA Bank & Trust that provides a range of financial services to individuals, families, and businesses in Pennsylvania. The company accepts savings accounts, interest bearing demand accounts, checking accounts, money market accounts, club accounts, certificates of deposit and IRAs, and other qualified plan accounts, as well as commercial checking accounts. Its loan portfolio includes first mortgage loans for the purchase, construction, or refinancing of one- to four-family residential real estate property; commercial real estate loans; home equity loans and lines of credit; and commercial and other consumer loans, as well as loans secured by deposits and personal unsecured loans. In addition, the company offers insurance benefits consulting services, such as health insurance, life insurance, short term and long term disability, dental, vision, 401(K) retirement planning, and individual health products, as well as asset management and trust, and investment services. As of September 30, 2021, it operated 21 community offices, including seven offices in Monroe County, three offices in Lehigh County, five offices in Northampton County, one office in Lackawanna County, one office in Luzerne County, one office in Chester County, two offices in Delaware County, and one office in Montgomery County, Pennsylvania. The company was founded in 1916 and is headquartered in Stroudsburg, Pennsylvania.
Contact
200 Palmer Street, Stroudsburg, PA, 18360
https://ir.essabank.com
IPO Date
April 4, 2007
Employees
232
Officers
Mr. James V. Fareri Esq.
General Counsel
Ms. Stephanie Lefferson
Corporate Secretary & Investor and Community Relations
Mr. Joseph E. Bonsick
Chief Banking Officer
Mr. Gary S. Olson
President, Chief Executive Officer & Director
Mr. Peter A. Gray
Senior EVice President & Chief Operating Officer
Mr. Charles D. Hangen
Executive Vice President & Chief Risk Officer
Mr. Allan A. Muto
Executive Vice President & Chief Financial Officer
Mr. Richard J. Howells
Director of Compliance
Mr. Thomas J. Grayuski
Chief Human Resource Officer & Senior Vice President
Mr. Robert L. Selitto
Senior Vice President & Controller